Midcap pharma moves when overall environment is buoyant: Sonam Udasi, IDBI Capital

In a chat with ET Now, Sonam Udasi, IDBI Capital shares his views on Midcap pharma stocks.

ET Now: What is your call on midcap pharma space?

Sonam Udasi: Midcap pharma generally moves when the overall environment is a little buoyant because midcap pharma you can really predict the continuity or sustainability of growth going forward. In large cap pharma there is some amount of visibility going forward.

Midcap tends to be a little volatile in a three year time frame that said in the current buoyant environment some of the names that are looking interesting would be something like Unichem valuations are attractive, growth is quite visible over the next two years so and also there is this view that globally MNCs will show lot more interest in Indian pharma and therefore valuations would tend to move up going forward.